Join
Live feed
·
INSIDERFilingvia Quantisnow
PTC Therapeutics Inc. logo

EXEC. VP AND CLO Boulding Mark Elliott sold $511,641 worth of shares (6,618 units at $77.31) and exercised 3,376 shares at a strike of $38.10, decreasing direct ownership by 3% to 117,659 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track PTCT (PTC Therapeutics Inc.) and more on Quantisnow.